BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18445043)

  • 1. Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression.
    Wimazal F; Baumgartner C; Sonneck K; Zauner C; Geissler P; Schur S; Samorapoompichit P; Müllauer L; Födinger M; Agis H; Sperr WR; Valent P
    Eur J Clin Invest; 2008 Jun; 38(6):447-55. PubMed ID: 18445043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes.
    Wimazal F; Germing U; Kundi M; Noesslinger T; Blum S; Geissler P; Baumgartner C; Pfeilstoecker M; Valent P; Sperr WR
    Cancer; 2010 May; 116(10):2372-81. PubMed ID: 20209617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on human basophil and eosinophil colonies in human blood mononuclear cell culture: presence of common basophil-eosinophil progenitors].
    Musashi M
    Hokkaido Igaku Zasshi; 1989 Sep; 64(5):567-79. PubMed ID: 2480321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
    Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
    Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation.
    Puccetti A; Bason C; Simeoni S; Millo E; Tinazzi E; Beri R; Peterlana D; Zanoni G; Senna G; Corrocher R; Lunardi C
    Clin Exp Allergy; 2005 Dec; 35(12):1599-607. PubMed ID: 16393326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndrome associated with marked eosinophilia and basophilia].
    Tanabe J; Sasaki S; Tamura T; Okamoto R; Sugamura R; Fujita H; Fukawa H; Kanamori H; Matsuzaki M; Mohri H
    Rinsho Ketsueki; 1992 Feb; 33(2):189-93. PubMed ID: 1635167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
    Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical biological features of mixed myeloid diseases].
    Gritsaev SV; Abldulkadyrov KM; Tiranova SA; Kapustin SI; Martynkevich IS; Bessmel'tsev SS; Rugal' VI; Bakaĭ MP
    Ter Arkh; 2004; 76(12):68-73. PubMed ID: 15724931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
    Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
    Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
    Valent P
    Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm.
    Tang G; Woods LJ; Wang SA; Brettler D; Andersen M; Miron PM; Pechet L; Woda BA; Hao S
    Hum Pathol; 2009 Aug; 40(8):1194-9. PubMed ID: 19427022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes.
    Füreder W; Schernthaner GH; Ghannadan M; Hauswirth A; Sperr WR; Semper H; Majlesi Y; Zwirner J; Götze O; Bühring HJ; Lechner K; Valent P
    Eur J Clin Invest; 2001 Oct; 31(10):894-901. PubMed ID: 11737228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
    Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
    Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
    Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
    Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric detection of degranulated basophils in chronic myeloid leukemia in accelerated phase.
    Stacchini A; Demurtas A; Godio L
    Cytometry B Clin Cytom; 2011 Mar; 80(2):122-4. PubMed ID: 20845367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms.
    Cantarini L; Volpi N; Carbotti P; Greco G; Aglianò M; Bellisai F; Giannini F; Alessandrini C; Grasso G; Galeazzi M
    J Clin Pathol; 2009 May; 62(5):442-7. PubMed ID: 19139036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.
    Berger D; Bauer K; Kornauth C; Gamperl S; Stefanzl G; Smiljkovic D; Sillaber C; Bettelheim P; Knöbl P; Schiefer AI; Greiner G; Thalhammer R; Hoermann G; Schwarzinger I; Staber PB; Sperr WR; Valent P
    Neoplasia; 2021 Dec; 23(12):1183-1191. PubMed ID: 34731787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
    Boehm A; Sperr WR; Leitner G; Worel N; Oehler L; Jaeger E; Mitterbauer M; Haas OA; Valent P; Kalhs P; Rabitsch W
    Eur J Clin Invest; 2008 Dec; 38(12):945-52. PubMed ID: 19021720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the peripheral eosinophil count in patients with acute eosinophilic myocarditis.
    Morimoto S; Kubo N; Hiramitsu S; Uemura A; Ohtsuki M; Kato S; Kato Y; Sugiura A; Miyagishima K; Mori N; Yoshida Y; Hishida H
    Heart Vessels; 2003 Sep; 18(4):193-6. PubMed ID: 14520487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.